Animal model studies indicate a candidate biomarker for sorafenib treatment of hepatocellular carcinoma

Elad Horwitz, Ilan Stein, Yinon Ben-Neriah, Eli Pikarsky*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Animal model studies indicate a candidate biomarker for sorafenib treatment of hepatocellular carcinoma'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science